Jeffrey S. Farrow

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
South San Francisco, CA
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
Sandra Thomson as attorney-in-fact
Source: Latest parsed Forms 3/4/5 signature
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Jeffrey S. Farrow

Form 4 holding Chief Financial Officer and Chief Strategy Officer

Tarsus Pharmaceuticals, Inc.

Security class
Stock Option (right to buy)
Shares / value
30,724
Estimated value
$1,795,733
Report date
05 Mar 2026
Price
$10.99
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Chief Financial Officer and Chief Strategy Officer

Tarsus Pharmaceuticals, Inc.

Security class
Restricted Stock Units
Shares / value
27,882
Estimated value
$310,133
Report date
15 Jun 2026
Price
$12.89
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Chief Financial Officer

Global Blood Therapeutics, Inc.

Security class
Restricted Stock Units
Shares / value
0
Estimated value
Report date
05 Oct 2022
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Chief Financial Officer

Global Blood Therapeutics, Inc.

Security class
Stock Option (Right to Buy)
Shares / value
0
Estimated value
Report date
05 Oct 2022
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Jeffrey S. Farrow

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .